Pharmaceuticals

Cell-based Biological Reagents Market Forecast: How Big Will It Be by 2030?

March 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the cell-based biological reagents market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Cell-based Biological Reagents Market expected to reach by 2030?

The cell-based biological reagents market has experienced substantial expansion recently. Its size is expected to increase from $13.78 billion in 2025 to $14.93 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.3%. Historically, this growth has been driven by several factors, including the escalation of drug discovery research efforts, increased expenditure on pharmaceutical R&D, the growing application of cell-based assays for toxicity assessments, innovations in cell culture methodologies, and the broader acceptance of standardized biological reagents.

The cell-based biological reagents market is projected to experience robust expansion in the coming years. By 2030, its valuation is forecast to reach $20.74 billion, exhibiting a compound annual growth rate (CAGR) of 8.6%. This anticipated growth during the forecast period stems from several factors, including the rising demand for predictive in vitro models, the expansion of personalized medicine research, the increasing application of AI-driven drug screening, higher investments in regenerative medicine studies, and a greater emphasis on complex disease modeling. Key developments shaping the market in the forecast period encompass the increasing embrace of 3D cell culture and assay platforms, a rising utilization of gene-edited and reporter cell lines, the growing need for high-throughput cell-based screening, the broadening scope of stem cell and primary cell applications, and an intensified focus on physiologically relevant models.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33059&type=smp

What Drivers Are Driving Adoption Within The Cell-based Biological Reagents Market?

An increasing emphasis on cell and gene therapies is anticipated to drive the expansion of the cell-based biological reagents market in the future. These therapies involve the utilization of living cells or genetic components to mend, substitute, or alter impaired cells or genes, aiming to treat or cure various illnesses. The growing application of cell and gene therapies stems from the rising occurrence of rare and genetic conditions, given their capacity to address root causes at a cellular or genetic level, presenting possible cures in situations where traditional treatments merely alleviate symptoms. Cell-based biological reagents facilitate cell and gene therapies by providing the necessary instruments and substances for the efficient cultivation, modification, and delivery of therapeutic cells or genetic material. As an illustration, in March 2024, IQVIA Holdings Inc., a US-based healthcare company specializing in clinical research services and analytics, reported that worldwide expenditure on cell and gene therapies climbed to $5.9 billion in 2023, representing a 38% increase compared to 2022. Consequently, the heightened focus on cell and gene therapies is propelling the growth of the cell-based biological reagents market.

What Segments Are Included Within The Cell-based Biological Reagents Market?

The cell-based biological reagents market covered in this report is segmented –

1) By Product Type: Assay Kits; Cell Lines; Reagents; Other Product Types

2) By Technology: Two Dimensional Cell Culture; Three Dimensional Cell Culture; High Throughput Screening Platforms; Stem Cell Technologies; Gene Edited Cell Platforms

3) By Application: Drug Discovery And Development; Toxicology And Safety Assessment; Disease Modeling; Regenerative Medicine; Basic Research

4) By End User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Contract Research Organizations; Clinical And Diagnostic Laboratories; Government And Public Health Agencies

Subsegments:

1) By Assay Kits: Cell Viability Assay Kits; Cytotoxicity Assay Kits; Proliferation Assay Kits; Apoptosis Assay Kits; Signal Transduction Assay Kits

2) By Cell Lines: Primary Cell Lines; Immortalized Cell Lines; Stem Cell Lines; Cancer Cell Lines; Transfected Cell Lines

3) By Reagents: Culture Media Reagents; Growth Factor Reagents; Enzyme Reagents; Supplement Reagents; Antibody Reagents

4) By Other Product Types: Cryopreservation Reagents; Labware Consumables; Transfection Reagents; Cell Sorting Reagents; Custom Reagents

How Are Emerging Trends Affecting The Progression Of The Cell-based Biological Reagents Market?

Major companies operating in the cell-based biological reagents market are focusing on developing human-induced pluripotent stem cell (iPSC) research products to advance drug discovery, disease modeling, and regenerative medicine applications. Human-induced pluripotent stem cell (iPSC) research products refer to integrated tools and workflows that enable the generation, maintenance, differentiation, and analysis of iPSCs for applications in biomedical research, including drug testing, disease modeling, and cell therapy development. For instance, in July 2024, BioServe Biotechnologies (India) Private Limited, an India-based biotechnology company, launched an advanced stem cell product line to advance regenerative medicine and drug development research. This line enhances biotech research through reliable iPSC generation, 3D organoid cultures, and targeted differentiation tools, minimizing experimental variability. They streamline drug discovery by offering human-specific models that reduce animal testing and accelerate toxicity assessments for faster therapy development. Ultimately, these products empower personalized medicine, enabling tissue regeneration for diseases such as diabetes or heart failure while reducing costs and rejection risks.

Who Are The Prominent Global Companies Shaping The Cell-based Biological Reagents Market Landscape?

Major companies operating in the cell-based biological reagents market are Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Corp., Danaher Corporation, GE Healthcare, Becton, Dickinson And Company, Corning Incorporated, Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., STEMCELL Technologies Inc., Miltenyi Biotec, Abcam plc, Promega Corporation, Takara Bio Inc., R&D Systems Inc., MP Biomedicals, Sino Biological, Cell Signaling Technology Inc., InvivoGen, Tocris Bioscience, and OPM Biosciences.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cell-based-biological-reagents-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Cell-based Biological Reagents Market?

North America was the largest region in the cell-based biological reagents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell-based biological reagents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cell-based Biological Reagents Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=33059&type=smp

Browse Through More Reports Similar to the Global Cell-based Biological Reagents Market 2026, By The Business Research Company

Biotechnology Reagents Market Report 2026

https://www.thebusinessresearchcompany.com/report/biotechnology-reagents-global-market-report

Biopreservation Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

Sequencing Reagents Market Report 2026

https://www.thebusinessresearchcompany.com/report/sequencing-reagents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795